MiMedx Files for Achilles Tendonitis IND Phase III Clinical Trial

MiMedx filed with FDA to initiate an Investigational New Drug Phase III Achilles Tendonitis clinical study comparing AmnioFix® Injectable to saline placebo.

The prospective, double blinded, randomized controlled trial will enroll 60 subjects with moderate to severe pain that failed conservative treatment for at least one month.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us